PTHS

Pelthos Therapeutics
PTHS

Overview Fund Trends Analyst Outlook Journalist POV

5 hedge funds and large institutions have $187K invested in Pelthos Therapeutics in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

80% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 5

Holders
5
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$172K
2
+$499
3
+$12

Top Sellers

1
-$626K
2
-$186K
3
-$14.8K
4
TRCT
Tower Research Capital (TRC)
New York
-$2.95K
5
UBS Group
UBS Group
Switzerland
-$443
Name Holding Trade Value Shares
Change 		Change in
Stake
Millennium Management
1
Millennium Management
New York
$172K
Geode Capital Management
2
Geode Capital Management
Massachusetts
$14.1K
UBS Group
3
UBS Group
Switzerland
$822
TRCT
4
Tower Research Capital (TRC)
New York
$107
Bank of America
5
Bank of America
North Carolina
$24
IC
6
Ikarian Capital
Texas
–
BFM
7
Boothbay Fund Management
New York
–
Wealth Enhancement Advisory Services
8
Wealth Enhancement Advisory Services
Minnesota
–
TCM
9
Tradewinds Capital Management
Washington
–